Longevity Health Holdings Inc (XAGE) - Kapitalizatsiyaning foydaga nisbati

Longevity Health Holdings Inc - XAGE emitenti grafik logotipi

Longevity Health Holdings (XAGE) mustahkam patent portfeliga tayangan holda to'qimalarni tiklovchi biomateriallarni yaratish orqali regenerativ kosmetologiyada innovatsiyalarni joriy etmoqda. Biznes zavod xarajatlaridan qochish uchun plazma gellarining distribyutsiyasini uchinchi tomon imkoniyatlari orqali kengaytirmoqda. O'sish Carmell mahsulotlarining bozorga chiqarilishi va premium parvarishga bo'lgan talab bilan ta'minlanmoqda. Asosiy baholash vositasi bo'lib xizmat qiluvchi GURU.Markets platformasidagi ushbu narxlar grafigi -0.60 qiymatida makro sikllardan mustaqilligini tasdiqlaydi.

Carmell Corp - XAGE Narx-foyda koeffitsiyenti (davr: 04.04.2025 - 20.09.2025)

Longevity Health Holdings kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Carmell Therapeutics|XAGE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Longevity Health Holdings Inc|XAGE - Kompaniyaning to‘liq qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga xususiy kapital Longevity Health Holdings|XAGE - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori carmellcosmetics.com|XAGE - Kompaniyaning jami aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Longevity Health Holdings|XAGE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati carmellcosmetics.com|XAGE - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Carmell Therapeutics Corporation|XAGE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Longevity Health Holdings|Shoshilinch likvidlik carmellcosmetics.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
XAGE - Sof daromad|Kutilayotgan foyda Longevity Health Holdings|XAGE - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Longevity Health Holdings|XAGE - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Carmell Corp|XAGE - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Longevity Health Holdings|XAGE - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi carmellcosmetics.com|XAGE - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Longevity Health Holdings
- emitentning tushumi va sotuvlari tafsilotlari:
XAGE - Daromad va sotish hajmi|Kompaniyaning kutilayotgan sotish hajmi Carmell Therapeutics|XAGE - P/S multiplikatori|Forvard P/S multiplikatori Longevity Health Holdings Inc
Kompaniyaning har tomonlama tahlili:Carmell Therapeutics XAGE
Carmell Therapeutics brendining mahsuloti

Regenerativ tibbiyot va bioximyodagi innovatsiyalar Longevity Health Holdings (XAGE) mahsulotlari uchun yuqori qo'shilgan qiymat yaratmoqda. Narx-foyda koeffitsiyenti dinamikasi ushbu texnologik ustunliklarning bozor qiymatini aks ettiradi. Ushbu ko'rsatkich kundalik valyuta kursi tebranishlarini hisobga olgan holda, biznes qiymatini uning sof foydasiga nisbatan o'lchaydi. O'sish grafigi investorlarning ishonchini tasdiqlaydi, garchi bu tendentsiya ortga qaytganda haddan tashqari ko'p to'lov qilish xavfini oshirsa-da. Aktiv yuqori texnologiyali investitsiya sifatida tasniflanadi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|PGNY - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ARDT (ardenthealth.com)|SEM - Narx-foyda koeffitsiyenti|Astrana Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E multiplikatori|NUTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AUNA|Narx-foyda koeffitsiyenti SBC Medical Group Holdings Inc SBC|Narxning foydaga nisbati Jeuveau EOLS|Kompaniya qiymatining sof foydaga nisbati CYH|SKIN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati MDWD (MediWound)|BTMD (biote.com) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti thejoint.com|DCGO (DocGo, Inc.) - P/E multiplikatori|Narxning foydaga nisbati PIII|Narx-foyda koeffitsiyenti GANX (Gain Therapeutics Inc.)|P/E multiplikatori EUDA Health (EUDA)|Basel Medical Group - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CLGN (CollPlant Ltd)|cuprina.com.sg - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CCM (Concord Medical Services Holdings)|AMS: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - P/E multiplikatori|Narx-foyda multiplikatori DHAI (DIH Holding US, Inc.)|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc